Company / Net Debt per Share
BioLife Solutions, Inc. Net Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$0.58
FY2025
5-year range
-$1.64 / $0.14
FY2021-FY2025
Trend
+64.9%
vs FY2024
Sector context
#80 of 100
Health Care
What the data says
BioLife Solutions, Inc.'s net debt per share of $-0.58 is lower than 80% of companies in the Health Care sector (FY2025). Net Debt per Share returned to growth in FY2025 after 2 years of decline, reaching $-0.58.
Based on SEC 10-K filings.
-0.58 in FY2025.
Improved from $-0.09 to $-0.58 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 100This company -$0.58 Sector average $7.44
▼
-107.8% below sector average
Key checks
Key Insights
- In FY2025, net debt per share increased 64.9% year-over-year.
- Ranks #80 out of 100 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2016.
- Lowest net debt per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.58 | +64.9% |
| FY2024 | -$1.64 | -1671.5% |
| FY2023 | -$0.09 | -164.7% |
| FY2022 | $0.14 | +108.8% |
| FY2021 | -$1.63 | +50.2% |
| FY2020 | -$3.26 | -887.1% |
| FY2019 | -$0.33 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | $0.23 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026